This NO deficit and consequent cerebral hypoperfusion (see Introduction) compromise further or even help to initiate neurodegenerative deregulations characteristic of AD, with increased both neuronal loss and levels of p-tau. This evidence concerns the gene MAPT and Alzheimer disease.